Technological development is key to improving the way hematologic cancer is diagnosed and treated. With this vision, the Josep Carreras Leukemia Research Institute is committed to the creation and implementation of new systems that push the limits of omics technologies. Spatial transcriptomics, the intersection of genomics, transcriptomics, and advanced microscopy, is one of them.